Global Ophthalmic Therapeutic Drugs Market, By Therapeutic Class (Antiallergy, Anti-VEGF Agents, Anti-Inflammatory, Antiglaucoma, and Others), By Disease Type (Dry Eye, Eye Allergy, Glaucoma, Eye Infection, Retinal Disorder, Uveitis, and Others), By Dosage Form (Gels, Eye Solutions, Capsules and Tablets, Eye Drops, and Ointments), By Route of Administration (Topical, Local Ocular, and Systemic), By Distribution Channel (Hospital Pharmacies, Drug Stores, Online Pharmacies, and Others), and By Region (North America, Europe, Asia Pacific, Middle East and Africa, South America) — Market Size, Share and Trends Analysis Report (2021–2030)

The Global Ophthalmic Therapeutic Drugs Market was valued at USD 37,500.2 million in 2020 and is expected to grow at a CAGR of 5.8% during the forecast period. Eyecare has transformed into a costly affair due to the increasing number of ophthalmic diseases, increasing treatment expenses, and the demand for cost-friendly ophthalmic disease therapeutics. According to the report shared by National Eye Institute, USD 139 billion is the estimated economic burden of vision-related issues in the United States. The increasing cases of blindness across the world is the main factor driving the global ophthalmic therapeutic drugs market. The rising awareness about eye-related issues and technological advancements are the main factors expected to accelerate the market growth.

In various developing economies, eye problems have emerged as the major threats to the status of the sight of their population. The rise in the number of diabetes patients in various countries caused diabetic retinopathy, which should be added to the checklist. Glaucoma is an eye disorder known for centuries, and it has been added to the priority list due to the problems in its early diagnosis and the need for lifelong treatment.

According to WHO, chronic eye disorders like cataracts and uncorrected refractive errors are the main reasons for vision loss. The former is the main cause in the countries having low and middle-income groups. But more than 80% of these problems can be easily cured by prescribing ophthalmic therapeutic drugs that act as vision management sources. Thus, the increasing prevalence of eye-related issues is estimated to cause a great impact on the overall market growth.

The lack of health insurance among people in the developing economies and the lack of insurance that covers all types of IOLs (Intraocular Lens) in developed economies is a main restraining factor. Lack of knowledge about ophthalmic disorders in developing countries, especially among the rural population, is a significant challenge faced by the ophthalmic therapeutic drugs market.

TABLE 1: GLOBAL OPHTHALMIC THERAPEUTIC DRUGS MARKET OVERALL SNAPSHOT

Global Ophthalmic Therapeutic Drugs Market

Market Segmentation

The global ophthalmic therapeutic drugs market is segmented on the basis of therapeutic class, disease type, dosage form, route of administration, and distribution channel.

Global Ophthalmic Therapeutic Drugs Market

FIGURE 1: GLOBAL OPHTHALMIC THERAPEUTIC DRUGS MARKET SEGMENTATION

Global Ophthalmic Therapeutic Drugs Market, by Therapeutic Class

Based on therapeutic class, the ophthalmic therapeutic drug market is segmented into antiallergy, anti-VEGF agents, anti-inflammatory, antiglaucoma, and others. Among these, the antiallergy segment is the fastest-growing segment in the market due to the high adoption rate and growth of market players. Different companies are conducting clinical studies for developing the advanced anti-inflammatory drug for an eye disorder which is expected to contribute to segment growth.

Global Ophthalmic Therapeutic Drugs Market, by Disease Type

On the basis of disease type, the global ophthalmic therapeutic drugs market is segmented into dry eye, eye allergy, glaucoma, eye infection, retinal disorder, retinal disorder, uveitis, and others.

Among all the segments, the glaucoma segment is the largest growing segment. The segment growth can be attributed to the launch of strong products and the rising sales volume of ophthalmic drugs required for glaucoma. Moreover, the rise in COVID-19 cases and related to eye disorders like conjunctivitis is estimated to contribute to market growth during the forecast period.

Global Ophthalmic Therapeutic Drugs Market, by Dosage Form

Based on dosage form, the market is segmented into gels, eye solutions, capsules and tablets, eye drops, and ointments. The eye drops segment is holding the highest market share owing to the ease of use and high patient compliance. Additionally, the development of eye drops to treat rare eye disorders and bioavailability is expected to drive the segment growth. Increasing technological advancements in ophthalmic therapeutic drug delivery to improve physicochemical stability and bioavailability are estimated to augment segment growth.

Global Ophthalmic Therapeutic Drugs Market, by Route of Administration

On the basis of the route of administration, the global therapeutic drugs market is segmented into topical, local ocular, and systemic. The local ocular segment is further segmented into subconjunctival, intravitreal, retrobulbar, and intracameral.

The local ocular segment is the largest growing segment and is expected to continue its dominance during the forecast period. Additionally, the continuous launch of new products to replace existing formulations is estimated to propel market growth.

Global Ophthalmic Therapeutic Drugs Market, by Distribution Channel

Based on the distribution channel, the global ophthalmic therapeutic drugs market is segmented into hospital pharmacies, drug stores, online pharmacies, and others. Among these, the hospital pharmacies is the largest segment since 2019 and is expected to hold the largest market share during the forecast period owing to the increasing prevalence of chronic eye disorders such as cataract, glaucoma and other retinal disorders. The increasing prevalence of the diseases among patients will result in increasing sales of ophthalmic therapeutic drugs in the market, which is expected to contribute to segment growth.

Global Ophthalmic Therapeutic Drugs Market, by Region

Based on the region, the global ophthalmic therapeutic drugs market is segmented into North America, Europe, Asia Pacific, Middle East and Africa and South America. North America is holding the largest market share in terms of revenue owing to the high prevalence of retinal disorders in the United States. Furthermore, the presence of the leading market players like Alcon and Pfizer Inc. is expected to drive the regional market growth during the forecast period.

Asia Pacific is expected to be the fastest-growing region in the global market during the forecast period. The regional market growth can be attributed to increasing consumer awareness and the increasing burden of ophthalmic disorders in the Asia Pacific. Apart from this many new entrants are entering the market by commercializing new treatment options for patients. This will immensely boost the regional market growth.

TABLE 2: GLOBAL OPHTHALMIC THERAPEUTIC MARKET OVERVIEW

 Ophthalmic Therapeutic Drugs Market

 Ophthalmic Therapeutic Drugs Market

FIGURE 3: GLOBAL OPHTHALMIC THERAPEUTIC MARKET (USD MILLION), 2021-2030

Recent Developments in The Global Ophthalmic Therapeutic Drugs Market

  • July 2020 - Quest Diagnostics received emergency use authorization from the US FDA for a laboratory technique that was launched for extracting viral RNA. It was designed for expanding the testing capacity of COVID-19 molecular tests.
  • September 2019 - Alcon introduced iLUX Patients Care Kits for supporting the practices to treat people suffering from dry eyes in the United States.
  • September 2019- Xelprose, an anti-glaucoma drug developed by Sun Pharma as well as SPARC was approved by USFDA.
  • August 2018 - DSM Biomedical Inc. and Aerie Pharmaceuticals, Inc. have collaborated with each other which focuses on novel drug delivery in ophthalmology.

What Does This Report Provide?

The report offers in-depth knowledge of the global ophthalmology therapeutic drugs market from a quantitative and qualitative basis over the forecast period. Apart from this, the study contains dynamic indicators along with the potential impact of the global market during the projected timeframe. The experts have also conducted an in-depth analysis of the key market players that are operating in the global market. It also covers major market opportunities, drivers, threats, barriers, and challenges of the market. The readers will get to know about the market shares of the key market companies that are present along with their product portfolio, production capabilities as well as growth strategies planned by them.

Market Segmentation

By Therapeutic Class

  • Antiallergy
  • Anti-VEGF Agents
  • Anti-inflammatory
    • Nonsteroidal Drugs
    • Steroidal Drugs
  • Antiglaucoma
  • Others

By Disease Type

  • Dry Eye
  • Eye Allergy
  • Glaucoma
  • Eye Infection
  • Retinal Disorders
    • Macular Degeneration
    • Diabetic Retinopathy
    • Others
  • Uveitis
  • Others

By Dosage Form

  • Gels
  • Eye Solutions
  • Capsules and Tablets
  • Eye Drops
  • Ointments

By Route of Administration

  • Topical
  • Local Ocular
    • Subconjunctival
    • Intravitreal
    • Retrobulbar
    • Intracameral
  • Systemic

By Distribution Channel

  • Hospital Pharmacies
  • Drug Stores
  • Online Pharmacies
  • Others

By Region:

North America Ophthalmic Therapeutic Drugs Market

  • North America, by Country
    • US
    • Canada
    • Mexico
  • North America, by Therapeutic Class
  • North America, by Disease Type
  • North America, by Dosage Form
  • North America, by Route of Administration
  • North America, by Distribution Channel

Europe Ophthalmic Therapeutic Drugs Market

  • Europe, by Country
    • Germany
    • U.K.
    • France
    • Italy
    • Spain
    • Russia
    • Rest of Europe
  • Europe, by Therapeutic Class
  • Europe, by Disease Type
  • Europe, by Dosage Form
  • Europe, by Route of Administration
  • Europe, by Distribution Channel

Asia Pacific Ophthalmic Therapeutic Drugs Market

  • Asia Pacific, by Country
    • China
    • India
    • Japan
    • South Korea
    • Australia
    • Rest of Asia Pacific
  • Asia Pacific, by Therapeutic Class
  • Asia Pacific, by Disease Type
  • Asia Pacific, by Dosage Form
  • Asia Pacific, by Route of Administration
  • Asia Pacific, by Distribution Channel

Middle East and Africa Ophthalmic Therapeutic Drugs Market

  • Middle East and Africa, by Country
    • UAE
    • Saudi Arabia
    • Qatar
    • South Africa
    • Rest of Middle East and Africa
  • Middle East and Africa, by Therapeutic Class
  • Middle East and Africa, by Disease Type
  • Middle East and Africa, by Dosage Form
  • Middle East and Africa, by Route of Administration
  • Middle East and Africa, by Distribution Channel

South America Ophthalmic Therapeutic Drugs Market

  • South America, by Country
    • Brazil
    • Argentina
    • Rest of South America
  • South America, by Therapeutic Class
  • South America, by Disease Type
  • South America, by Dosage Form
  • South America, by Route of Administration
  • South America, by Distribution Channel

Major Companies: In this report, the key companies that are studied are AbbVie Inc. (Allergan plc), Alcon Inc., Bausch & Lomb Incorporated, F. Hoffmann-La Roche Ltd (Genentech, Inc.), Novartis AG, Pfizer Inc., Regeneron Pharmaceuticals Inc., Santen Pharmaceutical Co., Ltd., Sun Pharmaceutical Industries Ltd., and Teva Pharmaceutical Industries Ltd. (Actavis Generics).

Objectives of this Report:

  • To estimate the market size for the ophthalmic therapeutic drugs market on a regional and global basis
  • To identify major segments in the ophthalmic therapeutic drugs market and evaluate their market shares and demand
  • To provide a competitive scenario for the market with major developments observed by the key companies in the historic years
  • To evaluate the key factors governing the dynamics of the ophthalmic therapeutic drugs market with their potential gravity during the forecast period
  • To evaluate the leading company-wise pricing analysis for the mentioned applications

Key Questioned Answered in the Study:

  • What are major growth drivers and market trends that are impacting the global ophthalmic therapeutic drugs market?
  • What is the market size both in terms of value and volume for the global ophthalmic therapeutic drugs market?
  • Who are the leading market players and who are the new market players that operate in the global market with an estimated market share?
  • What are the future investment pockets and opportunities in the global ophthalmic therapeutic drugs market?
  • Major list of customers and potential futuristic customer list along with an estimated buying volume
  • Impact of COVID-19 on the global ophthalmic therapeutic drugs market

Customization:

This study is customized to meet your specific requirements:

  • By sub-segment
  • By client-specific country, type, and application market analysis
  • Pricing analysis along with the potential list of customers
  • Product-specific competitive analysis

For more information, contact: sales@quincemarketinsights.com